FDA Approved: FLUTICASONE PROPIONATE AND SALMETEROL — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's Fluticasone Propionate and Salmeterol under an Original Application (NDA208799), a fixed-dose inhaled corticosteroid/long-acting beta-agonis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Fluticasone Propionate and Salmeterol (Fluticasone Propionate and Salmeterol)

Snippet

ORIG AP for FLUTICASONE PROPIONATE AND SALMETEROL (FLUTICASONE PROPIONATE AND SALMETEROL)